Effect of essential amino acid restriction on the growth of female C57BL mice and their implanted BW10232 adenocarcinomas.
D000230:Adenocarcinoma / Q000503:physiopathology*; D000596:Amino Acids / Q000008:administration & dosage*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003677:Deficiency Diseases / Q000503:physiopathology*; D005260:Female; D007532:Isoleucine / Q000008:administration & dosage; D007930:Leucine / Q000008:administration & dosage; D008239:Lysine / Q000008:administration & dosage; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000503:physiopathology*; D010649:Phenylalanine / Q000008:administration & dosage; D051381:Rats; D013912:Threonine / Q000008:administration & dosage; D014184:Transplantation, Homologous; D014364:Tryptophan / Q000008:administration & dosage; D014443:Tyrosine / Q000008:administration & dosage; D014633:Valine / Q000008:administration & dosage
D000596:Amino Acids; D007532:Isoleucine; D013912:Threonine; D014443:Tyrosine; D010649:Phenylalanine; D014364:Tryptophan; D007930:Leucine; D014633:Valine; D008239:Lysine